Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Alaa H. Falemban"'
Autor:
Nasser A. Elhawary, Imad A. AlJahdali, Iman S. Abumansour, Zohor A. Azher, Alaa H. Falemban, Wefaq M. Madani, Wafaa Alosaimi, Ghydda Alghamdi, Ikhlas A. Sindi
Publikováno v:
Human Genomics, Vol 17, Iss 1, Pp 1-15 (2023)
Abstract This review discusses the discovery, epidemiology, pathophysiology, genetic etiology, molecular diagnosis, and medication-based management of fragile X syndrome (FXS). It also highlights the syndrome’s variable expressivity and common como
Externí odkaz:
https://doaj.org/article/3c0b8312931542ca91a8be99b5e1acde
Autor:
Ghadi I. Alqurashi, Fahad S. Alqurashi, Khalid M. Alhusayni, Alaa H. Falemban, Yosra Z. Alhindi, Safaa M. Alsanosi, Abdullah R. Alzahrani, Saeed S. Al-Ghamdi, Nahla Ayoub
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 13, p 4282 (2023)
Methanol poisoning is a challenging issue due to its inducing acute multiple organ failures, and especially due to a lack of preparedness, available antidotes, and management protocols. The current study presents six cases of methanol poisoning that
Externí odkaz:
https://doaj.org/article/905fdabb60ad44c697f347ad3e693b56
Autor:
Reham M. Alhumaidi, Ghazi A. Bamagous, Safaa M. Alsanosi, Hamsah S. Alqashqari, Rawabi S. Qadhi, Yosra Z. Alhindi, Nahla Ayoub, Alaa H. Falemban
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 12, p 3960 (2023)
The simultaneous use of multiple drugs—termed ‘polypharmacy’—is often required to manage multiple physiological and biological changes and the interplay between chronic disorders that are expected to increase in association with ageing. Howev
Externí odkaz:
https://doaj.org/article/05c6104b87324756b3e0ac216d4702e8
Autor:
Fahad M. Althobaiti, Safaa M. Alsanosi, Alaa H. Falemban, Abdullah R. Alzahrani, Salma A. Fataha, Sara O. Salih, Ali M. Alrumaih, Khalid N. Alotaibi, Hazim M. Althobaiti, Saeed S. Al-Ghamdi, Nahla Ayoub
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 16, p 4769 (2022)
The Saudi Food and Drug Authority (SFDA) approved sodium-glucose cotransporter-2 (SGLT2) inhibitors in 2018. The efficacy and safety of empagliflozin (EMPA) have been confirmed in the U.S., Europe, and Japan for patients with type 2 diabetes mellitus
Externí odkaz:
https://doaj.org/article/8bccae80ffae457482f196cfb93c774a
Autor:
Ayoub, Ghadi I. Alqurashi, Fahad S. Alqurashi, Khalid M. Alhusayni, Alaa H. Falemban, Yosra Z. Alhindi, Safaa M. Alsanosi, Abdullah R. Alzahrani, Saeed S. Al-Ghamdi, Nahla
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4282
Methanol poisoning is a challenging issue due to its inducing acute multiple organ failures, and especially due to a lack of preparedness, available antidotes, and management protocols. The current study presents six cases of methanol poisoning that
Autor:
Shaima Alzaylaee, Lamis Babsail, Shahad Alshamrani, Alaa H Falemban, Safaa M Alsanosi, Yosra AL-Hindi
Publikováno v:
Medical Science. 26:1-5
Autor:
Reem A Radwan, Hassan H Alwafi, Yosra Z Alhindi, Alaa H Falemban, Shakeel A Ansari, Asim M Alshanberi, Nahla A Ayoub, Safaa M Alsanosi
Publikováno v:
Pharmacognosy Research. 14:269-275
Publikováno v:
International Journal of Life Science and Pharma Research.
Coronavirus disease 2019 (COVID-19) is an emerging respiratory disease that is caused by a novel coronavirus, which was first diagnosed in December 2019 in Wuhan, China, and subsequently spread to many other countries. Numerous countries have reporte
Autor:
Lamya Abdullah Almatrafi, Refal Essam Fagieha, Mohammed Abdulmuti Simsim, Alaa H. Falemban, Safaa M. Alsanosi, Deena Bukhary, Yosra AL -Hindi
Publikováno v:
International Journal of Life Science and Pharma Research.
While coronavirus disease 2019 has become a pandemic, the necessity of vaccination is crucial. Early 2020, scientists across the world started their vaccine trials to fight the pandemic. More than 46 million doses of a COVID-19 vaccines have been adm
Autor:
Alzahrani, Abdullah R, Mohamed, Doaa I, Nahas, Hebatallah H Abo, El-Waseef, Dalia Alaa El-Din Aly, Altamimi, Abdulmalik S, Youssef, Ibrahim H, Ibrahim, Ibrahim Abdel Aziz, Mohamed, Soha MY, Sabry, Yasmine Gamal, Falemban, Alaa H, Elhawary, Nasser Attia, Bamagous, Ghazi A, Jaremko, Mariusz, Saied, Essa M
Publikováno v:
Drug Design, Development & Therapy; Sep2024, Vol. 18, p3959-3986, 28p